Istituto Clinico Humanitas
Rozzano, Milano, 20089, Italy
NCT Number: NCT06220227
The goal of this monocentric retrospective observational study is to analyse, for the first time in literature, the role of the embryologist who freezes and thaws the embryos.
The primary objective of the study is to understand whether the embryologist who freezes and thaws the embryo influences the CPR (clinical pregnancy rate).
Secondary objectives, in case of statistically significant influence, are:
* Evaluate who influences more the CPR, between the embryologist who freezes the embryos and the embryologist who thaws the embryos. * Evaluate if the embryologist who freezes and thaws the embryo impacts more than the embryologist or the physician who performs the ET. * Evaluate whether the embryologists improve their performances, as their experience increases. * Evaluate, through an external validation test, whether the model used can also be applied at other PMA centres
The study will consider all the freezing (vitrifications) and thawing procedures, performed at Humanitas Fertility Center between January 2019 and June 2023.
The study will include the transfers of single blastocysts, cryopreserved at Humanitas Fertility Center. On the other hand, the blastocysts transferred from other centres and the donor blastocysts will be excluded from the study, as well as multiple blastocysts transfers and the LP cycles.
The embryologist's experience will be assessed in terms of number of previous cryopreservation (vitrification) and thawing procedures. We will include in the study all the embryologists who performed at least 50 freezing and thawing.
For the evaluation of the study objectives, data will be gathered using a specific internal web-based database.
The final model will be created by analysing the Humanitas Fertility Center dataset and validated using datasets extrapolated from similar population from the San Raffaele Hospital infertility centre
Looking for future studies?
Notify MeAll sexes
Observational
Rozzano, Milano, 20089, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The study database will include all the patients who performed a single cryopreserved blastocyst transfer, between January 2019 and June 2023, including also PGTA and repeated ART cycles.
The embryologist's experience will be assessed in terms of number of previous cryopreservation (vitrification) and thawing procedures. We will include in the study all the embryologists who performed at least 50 freezing and thawing.
Exclusion criteria
The blastocysts transferred from other centres and the donor blastocysts will be excluded from the study, as well as multiple blastocysts transfers and the LP cycles, to reduce the risk of selection bias or physician-embryologist couple bias.
The embryologists who performed less than 50 freezing and thawing will be excluded from the study.
Similarly, the first 50 procedures performed by each embryologist will not be counted in the data set.
Vitrification and thawing are crucial steps in infertility treatment. Vitrification solutions are aqueous cryoprotectant solutions that undergo solidification (and not freezing) when cooled at high rates to very low temperatures, thanks to an increase in viscosity.
Thawing consists in remove the cryoprotectants, warm and dilute the blastocyst.
Time frame: January 2019-June 2023
visualisation of the gestation sac in the uterus by ultrasound over the number of ET cycles performed
Istituto Clinico Humanitas
Other
The Embryologist's Impact on Blastocyst Vitrification and Thawing: a Monocentric Retrospective Study With an External Validation Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108665
Female Infertility, Female Urogenital Diseases
Nice, France
View Trial DetailsNCT07398924
Anovulatory Infertility, Female Infertility
Van, Di̇yarbakir, Turkey (Türkiye)
View Trial DetailsNCT06684951
Female Infertility, Female Urogenital Diseases
Baghdad, Iraq
View Trial DetailsNCT03737253
Female Infertility, Female Urogenital Diseases
Poznan, Poland
View Trial Details